249 related articles for article (PubMed ID: 25373629)
1. Authors' reply to Whitlock: Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.
Ignatowski TA; Spengler RN; Tobinick E
CNS Drugs; 2014 Dec; 28(12):1207-13. PubMed ID: 25373629
[No Abstract] [Full Text] [Related]
2. Comment on: "Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence".
Whitlock DR
CNS Drugs; 2014 Dec; 28(12):1205-6. PubMed ID: 25373628
[No Abstract] [Full Text] [Related]
3. Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.
Ignatowski TA; Spengler RN; Dhandapani KM; Folkersma H; Butterworth RF; Tobinick E
CNS Drugs; 2014 Aug; 28(8):679-97. PubMed ID: 24861337
[TBL] [Abstract][Full Text] [Related]
4. Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.
Tobinick E
CNS Drugs; 2011 Feb; 25(2):145-55. PubMed ID: 21254790
[TBL] [Abstract][Full Text] [Related]
5. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.
Tobinick E; Kim NM; Reyzin G; Rodriguez-Romanacce H; DePuy V
CNS Drugs; 2012 Dec; 26(12):1051-70. PubMed ID: 23100196
[TBL] [Abstract][Full Text] [Related]
6. Rapid improvement in severe long COVID following perispinal etanercept.
Tobinick E; Spengler RN; Ignatowski TA; Wassel M; Laborde S
Curr Med Res Opin; 2022 Dec; 38(12):2013-2020. PubMed ID: 35791687
[TBL] [Abstract][Full Text] [Related]
7. Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism.
Tobinick E
Medscape J Med; 2008 Jun; 10(6):135. PubMed ID: 18679537
[TBL] [Abstract][Full Text] [Related]
8. Immediate neurological recovery following perispinal etanercept years after brain injury.
Tobinick E; Rodriguez-Romanacce H; Levine A; Ignatowski TA; Spengler RN
Clin Drug Investig; 2014 May; 34(5):361-6. PubMed ID: 24647830
[TBL] [Abstract][Full Text] [Related]
9. Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.
Tobinick EL; Gross H
J Neuroinflammation; 2008 Jan; 5():2. PubMed ID: 18184433
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the physiology underlying the rapid clinical effects of perispinal etanercept in Alzheimer's disease.
Tobinick E
Curr Alzheimer Res; 2012 Jan; 9(1):99-109. PubMed ID: 22191562
[TBL] [Abstract][Full Text] [Related]
11. Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.
Tobinick EL; Gross H
BMC Neurol; 2008 Jul; 8():27. PubMed ID: 18644112
[TBL] [Abstract][Full Text] [Related]
12. Perispinal etanercept: potential as an Alzheimer therapeutic.
Griffin WS
J Neuroinflammation; 2008 Jan; 5():3. PubMed ID: 18186919
[TBL] [Abstract][Full Text] [Related]
13. Perispinal etanercept for treatment of Alzheimer's disease.
Tobinick E
Curr Alzheimer Res; 2007 Dec; 4(5):550-2. PubMed ID: 18220520
[TBL] [Abstract][Full Text] [Related]
14. Perispinal TNF-alpha inhibition for discogenic pain.
Tobinick EL; Britschgi-Davoodifar S
Swiss Med Wkly; 2003 Mar; 133(11-12):170-7. PubMed ID: 12715286
[TBL] [Abstract][Full Text] [Related]
15. Author's reply to Page: "Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept".
Tobinick E
CNS Drugs; 2013 May; 27(5):399-402. PubMed ID: 23580177
[No Abstract] [Full Text] [Related]
16. Novel use of modafinal to treat severe physical and cognitive impairment post-stroke.
Geffen S; Shum K; Tan HM
Intern Med J; 2013 Mar; 43(3):338. PubMed ID: 23441663
[No Abstract] [Full Text] [Related]
17. [The effect of cellex on cognitive and speech impairments in the acute stage of stroke].
Kovalenko AV; Safronova MN
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):40-44. PubMed ID: 25909788
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence.
Tobinick E
CNS Drugs; 2009 Sep; 23(9):713-25. PubMed ID: 19689163
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients.
Tobinick E; Davoodifar S
Curr Med Res Opin; 2004 Jul; 20(7):1075-85. PubMed ID: 15265252
[TBL] [Abstract][Full Text] [Related]
20. Perispinal etanercept for neuroinflammatory disorders.
Tobinick E
Drug Discov Today; 2009 Feb; 14(3-4):168-77. PubMed ID: 19027875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
